Author

C. Fiorini

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Organism:mouse· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

A. Regev· 1 shared A. Scarpa· 1 shared B. Cohen· 1 shared B. Rusev· 1 shared C. Neander· 1 shared C. Vicentini· 1 shared D. Filippini· 1 shared E. Fiorini· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Regev

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A genetic disorder reveals a hematopoietic stem cell regulatory network co-opted in leukemia

R. A. Voit, L. Tao, F. Yu, L. D. Cato, B. Cohen, X. Liao, C. Fiorini, S. K. Nandakumar, L. Wahlster, K. Teichert, A. Regev, V. G. Sankaran

The paper studies a genetic disorder caused by MECOM haploinsufficiency to identify a transcriptional network critical for HSC maintenance, which is also co-opted in high-risk leukemias.

bioRxiv · Dec 9, 2021Cell Biology

MAP Kinase inhibition reshapes tumor microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages

P. Delfino, C. Neander, D. Filippini, S. D'Agosto, C. Vicentini, E. Fiorini, F. Lupo, C. Fiorini, B. Rusev, G. Temgue Tane, F. De Sanctis, M. Simbolo, S. Ugel, V. Bronte, M. Fassan, , V. Corbo

This study shows that MEK inhibition in mouse pancreatic cancer reduces anti-inflammatory macrophages and enhances gemcitabine efficacy by altering the tumor microenvironment.

bioRxiv · Sep 8, 2019 · PreprintCancer Biology